Head of Finance

Job Title:          Head of Finance

Reports To:      Chief Executive Officer

Classification:  Exempt, Full-Time

Job Summary

Switch Therapeutics is seeking a talented Head of Finance to join the Switch team.

The Head of Finance works with the CEO, executive team, and scientific staff on financial policies, procedures, reporting and accountability for the organization. This is a hands-on position with responsibilities covering general accounting, payroll processing, budgeting, financial forecasting, financial reporting, grant reporting, and cash management.

This role will require full-time onsite work at our research facilities in South San Francisco.

The pay range for this position at commencement of employment is expected to be between $180,000- $200,000 per year depending on experience. Base pay offered may vary depending on other factors, including job-related knowledge, skills, and experience. The total compensation package for this position may also include equity in the Company, a discretionary annual bonus, and a full range of healthcare, and other benefits, including 401(k) eligibility and paid time off (including vacation, sick time, and parental leave). Details of participation in these benefit plans will be provided if a candidate receives an offer of employment.

If hired, the employee will be in an “at-will position,” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.

Interested applicants should send a resume and cover letter to careers@switchthera.com

Responsibilities:

The Head of Finance leads and directs the financial functions of the organization, including:

• Ensuring accurate & timely financial reporting: monthly, quarterly, and annual GAAP financial reports for management, investors, and grant agencies
• Safeguarding company assets (asset management and insurance) as well as ensuring appropriate cash management procedures are in place
• Coordinating with outside advisors, including auditors and tax advisors, for timely completion of financial audit and tax filings
• Preparing and filing regular financial reports and managing audit processes required by grant sponsors, including both federal and private grant sponsors
• Conceptualizing, documenting, and putting into practice appropriate processes, procedures, and controls to maximize efficiency and accuracy of financial management and to align with regulatory requirements
• Evaluating, selecting, and implementing financial reporting tools, including GL, budget & forecasting, project management or other software
• Developing strong working relationships and respect of internal partners through effective organization of the financial functions and participation in projects and strategy
• This is a hands-on role which may include data entry, journal entries, and reconciliations, and review in addition to the management role

Qualifications:

Required Education and Experience:

·        Bachelor’s degree in accounting

·        Minimum of 7 years’ accounting experience, with 5 years in the biotech industry

Preferred Education and Experience:

·        Public accounting experience

·        CPA licensure

·        IPO and/or M&A experience

·        Experience tracking costs in a process manufacturing environment

·        Project management and implementation skills

·        Demonstrated capabilities in financial forecasting and analysis

The successful candidate will have the following attributes:

·        Strong attention to detail, communication and organizational skills

·        Self-starter, able to contribute effectively in a fast-changing environment

·        Quick learner and comprehension of biotech industry and issues

·        The ability to work both independently and in a team-oriented environment

·        Commitment to quality and timely delivery of results

About Switch

Switch Therapeutics is an emerging biotechnology company developing RNAi therapies stemming from transformative technologies invented at Caltech, City of Hope, and Harvard Medical School.

The company’s conditionally activated siRNA (CASi) platform integrates RNA nanotechnology with RNA medicinal chemistry to create siRNA  prodrugs that can activate or suppress their own drug activities based on the presence or absence of specific RNA markers in mammalian cells. This gives CASi-based drugs the ability to target specific cells responsible for disease while sparing non-target cells from drug activity. 

Switch Therapeutics

241 E. Harris Ave

South San Francisco, CA 94080